A new clinical trial to test high-dose vitamin C in patients with COVID-19.
作者信息
Carr Anitra C
机构信息
Department of Pathology & Biomedical Science, University of Otago, Christchurch, PO Box 4345, Christchurch, 8140, New Zealand.
出版信息
Crit Care. 2020 Apr 7;24(1):133. doi: 10.1186/s13054-020-02851-4.
Abstract
摘要
相似文献
1
A new clinical trial to test high-dose vitamin C in patients with COVID-19.一项针对新冠肺炎患者测试高剂量维生素C的新临床试验。
Crit Care. 2020 Apr 7;24(1):133. doi: 10.1186/s13054-020-02851-4.
2
Letter to the Editor: Additional Recommendations before Intubation of COVID-19 Patients.致编辑的信：新型冠状病毒肺炎患者插管前的补充建议
Chin Med Sci J. 2020 Jun 30;35(2):110-111. doi: 10.24920/003744.
3
Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19.计算机断层扫描显示新冠病毒病危重症患者内脏脂肪增多。
Diabetes Care. 2020 Oct;43(10):e129-e130. doi: 10.2337/dc20-1333. Epub 2020 Aug 4.
4
Lung ultrasound early detection and monitoring in COVID-19 pneumonia: fact and fiction.新型冠状病毒肺炎中肺部超声的早期检测与监测：事实与假象
QJM. 2020 Aug 1;113(8):601-602. doi: 10.1093/qjmed/hcaa165.
5
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.对《免疫抑制对危重症COVID-19患者死亡率的影响》的回应
Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26.
6
Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.2019冠状病毒病患者的危重症：开展有效的临床和研究应对措施
JAMA. 2020 Apr 28;323(16):1559-1560. doi: 10.1001/jama.2020.5775.
7
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.康复血浆治疗新冠病毒病：可能性与挑战
JAMA. 2020 Apr 28;323(16):1561-1562. doi: 10.1001/jama.2020.4940.
8
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial.使用三碘甲状腺原氨酸治疗危重症COVID-19患者：一项新的临床试验。
Crit Care. 2020 May 8;24(1):209. doi: 10.1186/s13054-020-02934-2.
9
Prolonged illness after COVID-19.新冠病毒感染后的长期病症
Tidsskr Nor Laegeforen. 2020 Sep 29;140(14). doi: 10.4045/tidsskr.20.0753. Print 2020 Oct 13.
10
Study of critically ill patients with COVID-19 in New York City.纽约市新冠肺炎危重症患者的研究。
Lancet. 2020 Oct 10;396(10257):1064. doi: 10.1016/S0140-6736(20)32072-9.
引用本文的文献
1
Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy.草药和膳食补充剂作为意大利轻度新型冠状病毒感染辅助治疗手段
Nutrients. 2025 Jan 9;17(2):230. doi: 10.3390/nu17020230.
2
Vitamin C and COVID-19: should clinical trials be prioritised for low income settings and vitamin C-deficient populations?维生素C与2019冠状病毒病：低收入地区和维生素C缺乏人群是否应优先开展临床试验？
Crit Care Resusc. 2023 Oct 18;23(1):119-120. doi: 10.51893/2021.1.L1. eCollection 2021 Mar.
3
Dietary Supplement Use among Iranian Households during COVID-19 Epidemic Lockdown: Less Access in Those Who May Need More National Food and Nutrition Surveillance.新冠疫情封锁期间伊朗家庭的膳食补充剂使用情况：那些可能更需要国家食品和营养监测的人群获取途径较少
Int J Prev Med. 2023 Jul 27;14:99. doi: 10.4103/ijpvm.ijpvm_207_22. eCollection 2023.
4
Dietary supplements used by otolaryngology patients in Turkey during the COVID-19 pandemic: A cross-sectional survey.COVID-19大流行期间土耳其耳鼻喉科患者使用的膳食补充剂：一项横断面调查。
Eur J Integr Med. 2023 Jun;60:102249. doi: 10.1016/j.eujim.2023.102249. Epub 2023 Apr 6.
5
Perception, knowledge, and consumption pattern of dietary supplement used during COVID-19 pandemic among black Africans: Perspective of Nigerians.新冠疫情期间非洲黑人使用膳食补充剂的认知、知识及消费模式：尼日利亚人的视角
Dialogues Health. 2023 Dec;2:100106. doi: 10.1016/j.dialog.2023.100106.
6
The Role of Vitamin C: From Prevention of Pneumonia to Treatment of Covid-19.维生素C的作用：从预防肺炎到治疗新冠病毒病
Mater Today Proc. 2022 Nov 18. doi: 10.1016/j.matpr.2022.11.213.
7
Efficacy and safety of glycyrrhizic acid preparation treating comorbid liver injury in COVID-19: A systematic review.甘草酸制剂治疗新型冠状病毒肺炎合并肝损伤的疗效与安全性：一项系统评价
Front Pharmacol. 2022 Nov 3;13:1003697. doi: 10.3389/fphar.2022.1003697. eCollection 2022.
8
Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview.营养作为对抗 SARS-CoV-2 感染的个性化医学：特定女性群体的临床和肿瘤学选择概述。
Int J Mol Sci. 2022 Aug 15;23(16):9136. doi: 10.3390/ijms23169136.
9
Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review.维生素 C 和 D 与 COVID-19 的易感性、严重程度和进展：基于证据的系统评价。
Medicina (Kaunas). 2022 Jul 15;58(7):941. doi: 10.3390/medicina58070941.
10
The Interplay of Ascorbic Acid with Quinones-Chelators-Influence on Lipid Peroxidation: Insight into Anticancer Activity.抗坏血酸与醌类螯合剂的相互作用——对脂质过氧化的影响：对抗癌活性的深入了解
Antioxidants (Basel). 2022 Feb 13;11(2):376. doi: 10.3390/antiox11020376.
本文引用的文献
1
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.湖北省三级医院新型冠状病毒病例的临床特征。
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.
2
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
3
Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.维生素 C 输注对脓毒症和严重急性呼吸衰竭患者器官衰竭及炎症和血管损伤生物标志物的影响：CITRIS-ALI 随机临床试验。
JAMA. 2019 Oct 1;322(13):1261-1270. doi: 10.1001/jama.2019.11825.
4
Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score-based analysis of a before-after cohort study.维生素 C、氢化可的松和硫胺素联合治疗重症肺炎患者入住重症监护病房：一项前后队列研究的倾向评分匹配分析。
J Crit Care. 2018 Oct;47:211-218. doi: 10.1016/j.jcrc.2018.07.004. Epub 2018 Jul 5.
5
Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.危重症患者尽管推荐了肠内和肠外摄入，但仍存在维生素 C 缺乏和 Hypovitaminosis C。
Crit Care. 2017 Dec 11;21(1):300. doi: 10.1186/s13054-017-1891-y.
Zotero 插件